Clinical Trial Update: Clinical Classification of MAFLD Based Liver Biopsy

View source ↗

Summary

This clinical trial registry entry describes a study on classifying MAFLD using liver biopsy and notes that it is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Metabolic Dysfunction-associated Fatty Liver Disease
• Metabolic Dysfunction-associated Steatohepatitis

Snippet

Sponsor: Beijing Friendship Hospital | Conditions: Metabolic Dysfunction Associated Steatotic Liver Disease, Metabolic Dysfunction-associated Steatohepatitis (MASH) | Status: NOT_YET_RECRUITING